Characterization of a Thermostable Hepatitis B Vaccine Formulation
This article, published in the journal Vaccine, reports on the development of a new hepatitis B vaccine formulation that is stable against repeated freezing at -20°C and is also stable for 12 months at 37°C. The improved stability of this hepatitis B vaccine could be a key factor in ensuring vaccine effectiveness, extending immunization coverage, simplifying immunization logistics, and reducing the costs associated with the cold chain. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Braun LJ, Jezek J, Peterson S, et al.
Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Braun LJ, Jezek J, Peterson S, et al. Characterization of a Thermostable Hepatitis B Vaccine Formulation. Vaccine. 2009;27(34):4609-4614.